Nantahala Capital Management, LLC 13D and 13G filings for Evoke Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-19 4:15 pm Sale | 2025-12-17 | 13D | EVOKE PHARMA INC PAR $0.00 EVOK | Nantahala Capital Management, LLC | 0 0.000% | -268,431 (Position Closed) | Filing |
| 2025-11-04 11:40 am Purchase | 2025-11-03 | 13D | EVOKE PHARMA INC PAR $0.00 EVOK | Nantahala Capital Management, LLC | 268,431 15.990% | 13,792 (+5.42%) | Filing |